Want to join the conversation?
Michael Yee of RBC Capital Markets asks for an update on the endoscopy side. $CELG said studies are ongoing but the company has not seen data yet. The company is mainly looking at clinical responses, clinical remissions and then endoscopic improvement during the 12-week timeframe. $CELG expects to get some results in 2H16.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?